The largest database of trusted experimental protocols

6 protocols using primary antibody against bcl 2

1

Western Blot Analysis of Cell Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteins were extracted from cells using RIPA lysis buffer (Beyotime, China), and the concentrations were measured using BCA protein Assay (Beyotime, China). Proteins were separated using 10% SDS-PAGE and then transferred to PVDF membranes (Millipore, USA). After blocked in 5% nonfat milk and incubated with primary antibody against Bcl-2, Bax, pro-Caspaes-3, cleaved-Caspase-3, NLRP3, and GAPDH (Abcam, USA) overnight at 4°C, the membranes were incubated with HRP-conjugated secondary antibody at the room temperature for 1 hour. The bands were detected with the ECL detection system (Millipore, USA) and exposure to X-ray film.
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of BCL2 in CRC

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tumor samples from CRC patients were fixed in 10% formaldehyde, embedded in paraffin and then sectioned into slices. For IHC assay, tumor slices were firstly deparaffinized and rehydrated. After washing, slices were treated with H2O2 to reduce the endogenous peroxidase activities. Slices were then incubated with primary antibody against BCL2 (1:50, Abcam, Cambridge, UK) overnight at 4  °C. With three times washing in PBS, the slides were incubated with secondary streptavidin–horseradish peroxidase-conjugated antibody (1:3000, Abcam, Cambridge, UK) for 1 h, and reacted with 3,3-diaminobenzidine tetrahydrochloride (DAB) solution (Yeasen Biotech, Shanghai, China) for 5 min. Finally, slides were counterstained with hematoxylin solution (Beyotime Biotechnology, Shanghai, CHN) for 1 min, dehydrated and mounted with neutral gum.
+ Open protocol
+ Expand
3

Neurodegeneration Mechanism Study Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Poly-L-lysine (PLL) (10x) was purchased from Beijing Solarbio Science and Technology Co., Ltd. (Beijing, China). DMEM/F12 (1 : 1), Neurobasal Plus Medium, B27 Plus Supplement (50x), HBSS (1x), FBS, and 0.25% trypsin were obtained from Gibco (Grand Island, New York, USA). The Aβ25-35 fragment and dimethyl sulfoxide (DMSO) were purchased from Sigma (St. Louis, MO, USA). Donepezil hydrochloride, SB203580, and U46619 were obtained from Santa Cruz Biotechnology Inc. (Delaware, USA). L-Glutamine was obtained from Thermo Fisher (Massachusetts, USA). The rabbit polyclonal antibodies against MAP2 were purchased from Proteintech Group, Inc. (Chicago, USA). Rabbit monoclonal antibodies against p38 MAPK, p-p38 MAPK, caspase-3, cleaved caspase-3, and Bax were purchased from Cell Signaling Technology (Beverly, MA, USA). The primary antibody against Bcl-2 was purchased from Abcam (Cambridge, UK). Horseradish peroxidase- (HRP-) conjugated IgG secondary antibody was purchased from Beijing Bioss Biotechnology Co., Ltd. (Beijing, China), and the BCA protein assay kit was obtained from Beyotime Biotechnological Technology Co., Ltd. (Shanghai, China).
+ Open protocol
+ Expand
4

IHC Assay of BCL2 in CRC Tumor

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tumor samples from CRC patients were xed in 10% formaldehyde, embedded in para n and then sectioned into slices. For IHC assay, tumor slices were rstly depara nized and rehydrated. After washing, slices were treated with H 2 O 2 to reduce the endogenous peroxidase activities. Slices were then incubated with primary antibody against BCL2 (1:50, Abcam, Cambridge, UK) overnight at 4 °C. With three times washing in PBS, the slides were incubated with secondary streptavidin-horseradish peroxidaseconjugated antibody (1:3000, Abcam, Cambridge, UK) for 1h, and reacted with 3,3-diaminobenzidine tetrahydrochloride (DAB) solution (Yeasen Biotech, Shanghai, China) for 5 min. Finally, slides were counterstained with hematoxylin solution (Beyotime Biotechnology, Shanghai, CHN) for 1 minutes, dehydrated and mounted with neutral gum.
+ Open protocol
+ Expand
5

IHC Assay of BCL2 in CRC Tumor

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tumor samples from CRC patients were xed in 10% formaldehyde, embedded in para n and then sectioned into slices. For IHC assay, tumor slices were rstly depara nized and rehydrated. After washing, slices were treated with H 2 O 2 to reduce the endogenous peroxidase activities. Slices were then incubated with primary antibody against BCL2 (1:50, Abcam, Cambridge, UK) overnight at 4 °C. With three times washing in PBS, the slides were incubated with secondary streptavidin-horseradish peroxidaseconjugated antibody (1:3000, Abcam, Cambridge, UK) for 1h, and reacted with 3,3-diaminobenzidine tetrahydrochloride (DAB) solution (Yeasen Biotech, Shanghai, China) for 5 min. Finally, slides were counterstained with hematoxylin solution (Beyotime Biotechnology, Shanghai, CHN) for 1 minutes, dehydrated and mounted with neutral gum.
+ Open protocol
+ Expand
6

Bcl-2 Immunohistochemistry Scoring Procedure

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sections (3 µm) were depara nized, and the antigens were retrieved in citrate buffer (pH 6.0) under heat. Endogenous peroxidase was blocked using H 2 O 2 for 15 min, and non-speci c binding was blocked with 4% skim milk for 30 min. The sections were incubated with the primary antibody against Bcl-2 (1:100, Abcam, Cambridge, UK) overnight at 4 °C. The secondary antibody was added and incubated 30 min at room temperature and revealed using the Dako LSAB2 system (Dako, Glostrup, Denmark). The sections were counterstained with hematoxylin. The sections were scored as negative (-, < 10% of staining), weakly positive (+, 10%-25% of staining), moderately positive (++, 25%-75% of staining), and strongly positive (+++, > 75% of staining).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!